Recurrence patterns following irreversible electroporation for hepatic malignancies Journal Article


Authors: Langan, R. C.; Goldman, D. A.; D'Angelica, M. I.; DeMatteo, R. P.; Allen, P. J.; Balachandran, V. P.; Jarnagin, W. R.; Kingham, T. P.
Article Title: Recurrence patterns following irreversible electroporation for hepatic malignancies
Abstract: Background: Irreversible electroporation (IRE) has emerged as a novel, safe ablative therapy for peri-vascular lesions. However, there remains a paucity of data on long-term outcomes. Methods: We identified patients who underwent open IRE (1/2011-6/2015) for primary and secondary hepatic malignancies. Local ablation-zone recurrence (LR) was determined by cross-sectional imaging. Cumulative incidence (CumI) of LR was calculated and a competing risks regression assessed factors associated with LR. Results: Forty patients had 77 lesions treated. The majority of lesions were of colorectal origin (74%). Median tumor size was 1.3 cm (range 0.5-6). Most patients (86%) had prior systemic therapy and 29% received systemic therapy following IRE. With a median follow-up of 25.7 months (range 4.5-58.8 months), 10 lesions in 9 patients recurred locally (CumI: 13.4%, 95% CI: 7.8-22.2%). Median estimated time to LR was not reached and no LR occurred after 19 months. Factors significantly associated with LR included ablation zone size (HR 1.58; 95% CI 1.12-2.23; P = 0.0093) and body mass index (HR 1.21 95% CI 1.10-1.34; P = 0.0001). Conclusion: IRE LR rates were low after the treatment of well selected, small tumors. This technique is useful for lesions in anatomic locations precluding resection or thermal ablation.
Keywords: hepatocellular carcinoma; colorectal cancer; tumors; in-vivo; safety; radiofrequency ablation; hepatic metastases; metastatic; efficacy; hepatocellular-carcinoma; liver metastases; microwave ablation; thermal ablation; irreversible electroporation; percutaneous ablation; hepatic malignancy; cancer; liver directed therapy
Journal Title: Journal of Surgical Oncology
Volume: 115
Issue: 6
ISSN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2017-05-01
Start Page: 704
End Page: 710
Language: English
ACCESSION: WOS:000403347900008
DOI: 10.1002/jso.24570
PROVIDER: wos
PUBMED: 28493544
PMCID: PMC5647195
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronald P DeMatteo
    637 DeMatteo
  2. Peter Allen
    501 Allen
  3. William R Jarnagin
    903 Jarnagin
  4. T Peter Kingham
    609 Kingham
  5. Debra Alyssa Goldman
    158 Goldman
  6. Russell Charles Langan
    5 Langan